Spryte Medical

Spryte Medical, based in Bedford, Massachusetts, is a medical technology company founded in 2023. The company specializes in intravascular imaging and artificial intelligence, focusing on advanced neurovascular imaging technologies to improve the diagnosis and treatment of cerebrovascular diseases, such as stroke. The flagship product, the neuro Optical Coherence Tomography (nOCT) system, is an AI-enabled imaging platform that provides high-resolution visualization of the brain's vascular structures. This innovative technology allows for detailed imaging beyond the arterial lumen, offering insights into the brain's small and complex blood vessels. The nOCT system integrates seamlessly with existing procedural workflows, enhancing the understanding of neurovascular diseases and supporting the development of new therapies. Spryte Medical's nOCT system has received notable regulatory recognition, including FDA Breakthrough Device Designation and participation in the FDA’s Total Product Life Cycle Advisory Program. The company primarily serves clinicians and healthcare providers in neurointervention, aiming to improve procedural techniques and patient outcomes in neurovascular care.

• Employees32
• Founded2023